Agriculture has always evolved through better tools.

CRSP, NTLA, BEAM and EDIT offer distinct gene-editing opportunities, spanning commercial validation, late-stage catalysts and ...

Base editing and prime editing can be used to permanently fix pathogenic variants but require the development of a distinct drug to correct each pathogenic variant. Suppressor transfer RNAs (sup-tRNAs ...

In a paper, published on 24 August, scientists from the National Agri-Food and Biomanufacturing Institute genetically ...

Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), and Tianjin Medical ...

Urnov is a professor of molecular therapeutics at the University of California, Berkeley, and a director at its Innovative Genomics Institute. In May, news broke of a biomedical first: the on-demand ...

The CRISPR gene editing market is estimated at USD 4 billion in 2025 and is projected to reach USD 22 billion by 2035, expanding at a CAGR of 18.6% during the forecast period 2026–2035. The market is ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Next-generation gene-editing therapies are advancing in the clinic, but many companies in the field are early-stage, high-risk enterprises—not the profile that investors and pharma are seeking in ...

Forbes contributors publish independent expert analyses and insights. Juergen Eckhardt leads Bayer’s impact investment unit, Leaps by Bayer. Dr. David Liu, pictured with former lab members Holly Rees ...

Two undisclosed deaths in Chinese gene-editing trials renew concerns about trial oversight, safety reporting, and ...